DE69100991D1 - Pharmazeutische formulierungen. - Google Patents

Pharmazeutische formulierungen.

Info

Publication number
DE69100991D1
DE69100991D1 DE91907609T DE69100991T DE69100991D1 DE 69100991 D1 DE69100991 D1 DE 69100991D1 DE 91907609 T DE91907609 T DE 91907609T DE 69100991 T DE69100991 T DE 69100991T DE 69100991 D1 DE69100991 D1 DE 69100991D1
Authority
DE
Germany
Prior art keywords
pct
sec
pharmaceutical formulations
date
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE91907609T
Other languages
English (en)
Other versions
DE69100991T2 (de
Inventor
Luigi Giovanni Mapelli
Marco Giuseppe Raffael Marconi
Marco Zema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharmaceuticals SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Application granted granted Critical
Publication of DE69100991D1 publication Critical patent/DE69100991D1/de
Publication of DE69100991T2 publication Critical patent/DE69100991T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE91907609T 1990-04-17 1991-04-09 Pharmazeutische formulierungen. Expired - Lifetime DE69100991T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02005590A IT1246383B (it) 1990-04-17 1990-04-17 Metodo per il mascheramento del sapore di farmaci
PCT/EP1991/000689 WO1991016043A1 (en) 1990-04-17 1991-04-09 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DE69100991D1 true DE69100991D1 (de) 1994-02-24
DE69100991T2 DE69100991T2 (de) 1994-05-05

Family

ID=11163454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE91907609T Expired - Lifetime DE69100991T2 (de) 1990-04-17 1991-04-09 Pharmazeutische formulierungen.

Country Status (19)

Country Link
US (1) US5409711A (de)
EP (1) EP0477333B1 (de)
JP (1) JP3193041B2 (de)
KR (1) KR0164863B1 (de)
AT (1) ATE99927T1 (de)
AU (1) AU635133B2 (de)
CA (1) CA2058946C (de)
DE (1) DE69100991T2 (de)
DK (1) DK0477333T3 (de)
ES (1) ES2048594T3 (de)
HK (1) HK12495A (de)
IE (1) IE64274B1 (de)
IT (1) IT1246383B (de)
NZ (1) NZ237824A (de)
PT (1) PT97369B (de)
RU (1) RU2085190C1 (de)
SA (1) SA99191025A (de)
WO (1) WO1991016043A1 (de)
ZA (1) ZA912793B (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704146B1 (fr) * 1993-04-19 1995-07-13 Cripdom Microcapsules d'acide acétylsalicylique à libération contrôlée.
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
BR9705470A (pt) * 1997-11-12 1999-07-06 Ind Quimica E Farmaceutica Sch Processo para a preparação de uma composição farmaceutica oral composição farmaceutica oral e kit compreendendo uma composição farmacêutica
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP3143433B2 (ja) * 1998-07-07 2001-03-07 三基商事株式会社 マスキング組成物
FR2781152B1 (fr) * 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
DE19835823A1 (de) * 1998-08-10 1999-10-07 Lindopharm Gmbh Pharmazeutische Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung sowie aus ihr hergestellte wässerige Suspension
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
BR0009557A (pt) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Suspensão farmacêutica para beber de ibuprofeno
IN191239B (de) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
JP3718398B2 (ja) * 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
US7999118B2 (en) 2000-01-18 2011-08-16 Albemarle Corporation Process for producing N-halogenated hydantoins
US6508954B1 (en) * 2000-01-18 2003-01-21 Albemarle Corporation 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties
US20050049420A1 (en) * 2000-01-18 2005-03-03 Elnagar Hassan Y. Process for producing N-halogenated organic compounds
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
ES2284643T3 (es) 2000-04-20 2007-11-16 Novartis Ag Composicion de revestimiento enmascarante del sabor.
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US6986910B2 (en) * 2001-06-28 2006-01-17 Albemarle Corporation Microbiological control in poultry processing
US20030077365A1 (en) * 2001-06-28 2003-04-24 Howarth Jonathan N. Environmentally-friendly microbiological and microbiocidal control in aqueous systems
US6919364B2 (en) * 2001-06-28 2005-07-19 Solution Biosciences, Inc. Microbiological control in animal processing
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20090178587A9 (en) * 2001-10-09 2009-07-16 Nalepa Christopher J Control of biofilms in industrial water systems
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
CN100337630C (zh) * 2002-03-12 2007-09-19 布里斯托尔-迈尔斯斯奎布公司 可口的口服悬浮液及其制备方法
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
IL164221A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
US20060073216A1 (en) * 2002-12-26 2006-04-06 Solution Biosciences, Inc. Compositions and methods for control of bovine mastitis
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7901276B2 (en) 2003-06-24 2011-03-08 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20040265446A1 (en) * 2003-06-24 2004-12-30 Mcnaughton James L. Microbiocidal control in the processing of poultry
US20040265445A1 (en) * 2003-06-24 2004-12-30 Liimatta Eric W. Microbiocidal control in the processing of poultry
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
WO2005072113A2 (en) * 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (de) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Geschmacksverdeckende pharmazeutische Zusammensetzungen mit magenlöslichen Porenbildnern
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2007031407A (ja) * 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US7914365B2 (en) * 2005-12-01 2011-03-29 Albemarle Corporation Microbiocidal control in the processing of meat-producing four-legged animals
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
EP2089013B1 (de) * 2006-10-20 2017-09-27 Johnson & Johnson Consumer Inc. Kombination von acetaminophen mit ibuprofen zur behandlung von schmerzen.
CA2667207A1 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
CN101380474B (zh) * 2007-09-06 2012-07-25 北京大学 用于口服制剂的pH敏感性固体药物组合物及制备方法
KR101753411B1 (ko) * 2008-11-25 2017-07-03 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정 및 그의 제조 방법
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
WO2011085181A1 (en) * 2010-01-08 2011-07-14 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
WO2012169614A1 (ja) * 2011-06-10 2012-12-13 ニプロ株式会社 口腔内崩壊錠の製造方法
CA2884119A1 (en) 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
AU2013318360A1 (en) 2012-09-18 2015-03-26 Mcneil-Ppc, Inc. Sustained release oral dosage forms comprising low melting propionic acid derivative particles
US9820894B2 (en) 2013-03-22 2017-11-21 The Procter & Gamble Company Disposable absorbent articles
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
EP3398587B1 (de) * 2015-12-28 2023-08-02 SSP Co., Ltd., Japan Kompaktierte pharmazeutisches präparat
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10828208B2 (en) 2016-11-21 2020-11-10 The Procte & Gamble Company Low-bulk, close-fitting, high-capacity disposable absorbent pant
CN111388444B (zh) * 2020-03-18 2022-05-20 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ZA912793B (en) 1992-12-30
EP0477333B1 (de) 1994-01-12
IT9020055A0 (it) 1990-04-17
DE69100991T2 (de) 1994-05-05
US5409711A (en) 1995-04-25
PT97369B (pt) 1998-08-31
NZ237824A (en) 1992-03-26
DK0477333T3 (da) 1994-03-14
JPH05500674A (ja) 1993-02-12
AU7681291A (en) 1991-11-11
KR0164863B1 (ko) 1999-01-15
IT9020055A1 (it) 1991-10-17
CA2058946C (en) 2001-11-20
PT97369A (pt) 1991-12-31
CA2058946A1 (en) 1991-10-18
IE64274B1 (en) 1995-07-26
AU635133B2 (en) 1993-03-11
EP0477333A1 (de) 1992-04-01
IE911272A1 (en) 1991-10-23
WO1991016043A1 (en) 1991-10-31
KR920702618A (ko) 1992-10-06
RU2085190C1 (ru) 1997-07-27
HK12495A (en) 1995-02-03
SA99191025A (ar) 2005-12-03
ATE99927T1 (de) 1994-01-15
ES2048594T3 (es) 1994-03-16
JP3193041B2 (ja) 2001-07-30
IT1246383B (it) 1994-11-18

Similar Documents

Publication Publication Date Title
ATE99927T1 (de) Pharmazeutische formulierungen.
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
ATE19589T1 (de) Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung.
AU678859B2 (en) Immediate release tablet cores of insoluble drugs having sustained release coating
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
ATE116543T1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
TR199800777T2 (xx) Zay�f ��z�n�rl��e sahip bazik ila�lar i�in kontroll� salma form�lasyon. Zay�f ��z�n�rl��e sahip bazik ila�lar i�in kontroll� salma form�lasyonu.
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
CA2282082A1 (fr) Microgranules contenant du cisplatine
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
PH27446A (en) Compound with gastric acid inhibitory effect
ATE104146T1 (de) Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs.
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
BR0007513A (pt) Fosfatidilinositóis sulfatados, sua preparação euso
ES2164849T3 (es) Soluciones acuosas con sabor enmascarado que contienen ibuprofeno y mentol.
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition